Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Sep 29, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
When a cutaneous wound is created following Mohs micrographic surgery and standard excisions, a decision is made to either allow the wound to heal by second intention ("leave open") or repair the wound ("close"). The decision may depend on patient characteristics, wound location, wound size or wound characteristics.
When the decision is made to repair the wound, the majority of wounds are reconstructed using two layers of sutures: a deep (subcutaneous) layer and a top (cutaneous) layer.
This study aims to investigate whether complex linear closure versus second intention healing for cutan...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Able to give informed consent themselves
- • Patient scheduled for cutaneous surgical procedure below the knee with a lesion excision diameter of at least 1 cm.
- • Willing to return for follow up visit
- Exclusion Criteria:
- • Incarceration
- • Under 18 years of age
- • Pregnant Women
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials